Jounce Therapeutics, Inc.
USD1.88
+0.00 (+0.00%)
CEO
Kimberlee Cobleigh Drapkin CPA
IPO Date
2017-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.92
Prev. Close
$1.88
Day Low
$1.88
Day High
$1.93
52W Low
$0.58
52W High
$5.37
Market Cap
$0.10B
Volume
11.60M
| -4.6 |
| 31 Dec 2020 | FY | 100.0% | -70.3% | -20.7% | -18.0% | 0.08 | 10.94 | -5.7 |
| 31 Dec 2019 | FY | 100.0% | 38.4% | 32.5% | 27.6% | 0.11 | 12.06 | 5.1 |
| 31 Dec 2018 | FY | 100.0% | -42.0% | -26.3% | -12.8% | 0.00 | 2.93 | -4.0 |
| 31 Dec 2017 | FY | 100.0% | -23.0% | -9.8% | -5.5% | 0.00 | 4.09 | -23.3 |
| 31 Dec 2016 | FY | 100.0% | -36.8% | -19.1% | -5.1% | 0.00 | 1.67 | -38.0 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -63.6% | -53.9% | 0.00 | 6.80 | -11.2 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | 1965.6% | -139.9% | 0.00 | 1.16 | -36.2 |
| -1.0 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -21.2% | -17.7% | 0.08 | 6.78 | -1.2 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -19.8% | -17.4% | 0.07 | 9.87 | -2.3 |
| 31 Dec 2021 | Q4 | 100.0% | 111502.6% | 0.0% | 0.0% | 0.08 | 10.10 | 3565.6 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -12.0% | -10.7% | 0.06 | 12.67 | -3.2 |
| 30 Jun 2021 | Q2 | 100.0% | -15.8% | -1.4% | -1.3% | 0.06 | 16.23 | -21.7 |
| 31 Mar 2021 | Q1 | 100.0% | -1724.2% | -9.5% | -8.7% | 0.06 | 20.66 | -4.4 |
| 31 Dec 2020 | Q4 | 100.0% | 56.9% | 16.8% | 14.5% | 0.08 | 10.94 | 1.9 |
| 30 Sept 2020 | Q3 | 0.0% | 0.0% | -23.7% | -18.3% | 0.17 | 6.60 | -2.8 |